Antiseptic Use and Dressing Application
Study Details
Study Description
Brief Summary
The purposes of the study are:
-
To compare the local efficacy (skin colonization) of 2 commercialized antiseptics used for the disinfection of the dressing application for an epicutaneocavous catheter (EPI).
-
To evaluate whether the bacteria responsible for nosocomial infection is comparable to the flora diagnosed at the EPI site.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 4 |
Detailed Description
Epicutaneocavous catheter is a significant risk factor for nosocomial infection in newborn infants. These infections have been related to local bacterial colonisation. Therefore thorough disinfection should lower the risk of nosocomial infection. However, the local efficacy of antiseptic use has not yet been clearly evaluated in this situation.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Active Comparator: 2 Biseptine |
Procedure: disinfection efficacy using Biseptine
Detersion and antiseptic application when changing catheter dressing
Other Names:
|
Active Comparator: 1 Amukin |
Procedure: disinfection efficacy using Amukin
Detersion and antiseptic application when changing catheter dressing
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Efficacy on skin colonization of two commercially available antiseptics [2 weeks]
Secondary Outcome Measures
- In case of nosocomial infection, relationship with skin bacteria [2 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
All infants admitted to the Neonatal Intensive Care Unit
-
Epicutaneocavous catheter insertion indication
Exclusion Criteria:
- Epicutaneocavous catheter not inserted within the Unit
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Maternite Regionale Universitaire | Nancy | France | 54042 |
Sponsors and Collaborators
- Maternite Regionale Universitaire
Investigators
- Study Director: Jean-Michel HASCOET, MD, University of NANCY, France
- Principal Investigator: Monique LUX, Pharmacist, Maternite Regionale Universitaire
Study Documents (Full-Text)
None provided.More Information
Publications
- MRAP190406